Calumet (NASDAQ:CLMT) Director Sells $268,000.00 in Stock

Calumet, Inc. (NASDAQ:CLMT) Director Daniel Sajkowski sold 20,000 shares of the business’s stock in a transaction on Monday, June 2nd. The stock was sold at an average price of $13.40, for a total value of $268,000.00. Following the transaction, the director directly owned 81,959 shares of the company’s stock, valued at $1,098,250.60. The trade was a 19.62% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Calumet Stock Performance

CLMT stock traded up $0.63 during mid-day trading on Thursday, reaching $30.22. The company had a trading volume of 1,721,709 shares, compared to its average volume of 1,367,486. The firm has a fifty day simple moving average of $22.92 and a 200 day simple moving average of $19.82. The company has a market capitalization of $2.62 billion, a price-to-earnings ratio of -70.28 and a beta of 1.24. Calumet, Inc. has a fifty-two week low of $7.68 and a fifty-two week high of $30.35.

Institutional Investors Weigh In On Calumet

Several large investors have recently modified their holdings of CLMT. Islay Capital Management LLC purchased a new position in shares of Calumet during the fourth quarter worth approximately $25,000. Aster Capital Management DIFC Ltd boosted its stake in Calumet by 294.7% during the 4th quarter. Aster Capital Management DIFC Ltd now owns 1,646 shares of the oil and gas company’s stock worth $33,000 after purchasing an additional 1,229 shares during the period. Global Retirement Partners LLC purchased a new position in Calumet during the 4th quarter worth $34,000. Covestor Ltd increased its stake in Calumet by 29.1% in the fourth quarter. Covestor Ltd now owns 2,180 shares of the oil and gas company’s stock valued at $43,000 after purchasing an additional 492 shares during the period. Finally, Amalgamated Bank acquired a new position in Calumet in the second quarter valued at $37,000. 34.41% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the company. Zacks Research raised Calumet from a “strong sell” rating to a “hold” rating in a report on Thursday, November 6th. HC Wainwright reiterated a “buy” rating and issued a $33.00 price objective on shares of Calumet in a report on Monday, November 10th. UBS Group reissued a “neutral” rating and set a $26.00 target price on shares of Calumet in a research report on Friday, February 13th. Wall Street Zen downgraded Calumet from a “buy” rating to a “hold” rating in a report on Sunday, December 14th. Finally, The Goldman Sachs Group raised their price objective on shares of Calumet from $20.00 to $24.00 and gave the stock a “buy” rating in a report on Friday, January 30th. Four research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $22.83.

Calumet Company Profile

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.